Applied DNA Sciences, Inc.
APDN
$4.83
$0.3156.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.00% | -18.28% | 29.70% | -3.85% | -143.29% |
| Total Depreciation and Amortization | -66.63% | -65.51% | -48.87% | -30.22% | -12.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -593.76% | 13.53% | -7,793.58% | -158.49% | 83.90% |
| Change in Net Operating Assets | -215.08% | -132.76% | -146.60% | -112.55% | -33.36% |
| Cash from Operations | -20.32% | -74.91% | -120.52% | -93.37% | -53.40% |
| Capital Expenditure | 36.87% | 54.00% | 64.24% | -109.52% | -194.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 36.87% | 54.00% | 62.78% | -132.31% | -235.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 504.43% | 43,869.30% | -- | -1.75% | -78.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 200.00% | -- | -- | -- |
| Cash from Financing | 491.34% | 56,339.03% | -- | -1.75% | -78.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 140.20% | 167.69% | 90.15% | -104.60% | -240.05% |